a year ago
LNTH
AnalystsJustin WalshJustin Walsh's Stock Forecasts
AnalystsJustin Walsh
Analyst Ranking
Top 18%
#887 out of 5116 analysts
Average Return
+9.81%
Win Rate
35%14 out of 40
Risk vs Reward
Poor
Good
Justin Walsh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +334.36% | $45.23 | $196.46 | 2025-09-18 - 2025-11-28 | Strong Buy |
Alto Neuroscience IncANRO | +269.33% | $3.75 | $13.85 | 2024-12-16 - 2025-11-28 | Strong Buy |
Clene IncCLNN | +266.08% | $2.83 | $10.36 | 2025-04-23 - 2025-11-28 | Strong Buy |
Harrow IncHROW | +261.36% | $5.90 | $21.32 | 2022-05-20 - 2023-05-19 | Strong Buy |
Perspective Therapeutics IncCATX | +254.25% | $2.52 | $8.92 | 2023-11-15 - 2024-11-14 | Strong Buy |
Justin Walsh Analyst Color
Get additional color on Justin Walsh's coverage of popular stocks
a year ago
LNTH
2 years ago
CATX
2 years ago
LNTH
Justin Walsh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | 1 | Strong Buy | $83.00 | -57.75% | Initiates Coverage On | 2 months ago |
Lantheus Holdings IncLNTH | 10 | Strong Buy | $84.00 | +42.69% | Maintains | 2 months ago |
Volitionrx LtdVNRX | 1 | Strong Buy | $3.00 | +831.68% | Initiates Coverage On | 6 months ago |
Biolinerx LtdBLRX | 2 | Strong Buy | $12.00 | +245.82% | Upgrades | 6 months ago |
Clene IncCLNN | 1 | Strong Buy | $30.00 | +189.58% | Initiates Coverage On | 7 months ago |
Serina Therapeutics IncSER | 1 | Strong Buy | $11.00 | +158.22% | Initiates Coverage On | 9 months ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $18.00 | +29.96% | Initiates Coverage On | a year ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | a year ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $22.00 | N/A | Maintains | 2 years ago |
Trisalus Life Sciences IncTLSI | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Achieve Life Sciences IncACHV | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Cytosorbents CorpCTSO | 2 | Strong Buy | $4.00 | N/A | Reinstates | 2 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 2 years ago |
Theratechnologies IncTHTX | 1 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $360.00 | N/A | Initiates Coverage On | 3 years ago |
Viewray IncVRAYQ | 2 | Hold | $1.00 | N/A | Downgrades | 3 years ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $175.00 | N/A | Initiates Coverage On | 3 years ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $440.00 | N/A | Initiates Coverage On | 3 years ago |
Plus Therapeutics IncPSTV | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Fusion Pharmaceuticals IncFUSN | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Point Biopharma Global IncPNT | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Harrow IncHROW | 1 | Strong Buy | $20.00 | N/A | Maintains | 4 years ago |
Curis IncCRIS | 2 | Strong Buy | $200.00 | N/A | Maintains | 4 years ago |
Compass Therapeutics IncCMPX | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 4 years ago |
Alphaton Capital CorpATON | 1 | Strong Buy | $800.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.